News and publishing service for psychedelic related companies
Contact us:
512.354.7000
twitter
facebook
linkedin
News and publishing service for psychedelic related companies
Home
About
Clients
NewsRoom
Solutions
Events
Contact
PNW Headlines
NRx Pharmaceuticals Inc. (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals Inc. (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies
NRx Pharmaceuticals Inc. (NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition
NRx Pharmaceuticals Inc. (NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
Global Psychedelic Week 2025 to Unite 5,000 People Across 100 Countries
PsychedelicNewsBreaks
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Eliminates Balance Sheet Debt Through Anson Equity Conversion
NRx Pharmaceuticals Inc. (NRXP)
December 18, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With TMS for Depression Treatment
NRx Pharmaceuticals Inc. (NRXP)
December 3, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KETAFREE With July 2026 Review Goal Date
NRx Pharmaceuticals Inc. (NRXP)
December 2, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for Dec. 2
NRx Pharmaceuticals Inc. (NRXP)
December 2, 2025
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at NobleCon21
NRx Pharmaceuticals Inc. (NRXP)
December 1, 2025
View More PsychedelicNewsBreaks
PsychedelicNewsWire Articles
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies
NRx Pharmaceuticals, Inc. (NRXP)
October 16, 2025
Global Psychedelic Week 2025 to Unite 5,000 People Across 100 Countries
Global Psychedelic Week
October 14, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition
NRx Pharmaceuticals, Inc. (NRXP)
October 7, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals, Inc. (NRXP)
September 2, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
NRx Pharmaceuticals, Inc. (NRXP)
August 22, 2025
View All PsychedelicNewsWire Articles
Public Press Releases
Filter Releases
Filters
Sector
Aerospace and Defense
Banking and Finance
Banking
Biotechnology
Internet
Media
Metal and Mineral
Medical Marijuana
Chemicals
Computer
Consumer Goods
Pharmaceutical
Oil & Energy
Real Estate
Software
Energy
Entertainment
Food and Beverage
Healthcare
Telecommunications
Transportation
Utilities
Remove All Filters
Symbol
Release
Time
Source
{{ release.qmtopics.qmsymbol[0].symbol }}
{{ release.headline }}
{{ release.datetime | amDateFormat:'hh:mm A'}}
{{ release.source }}
Load More
PsychedelicNewsWire Currently Accepts
Bitcoin
Bitcoin Cash
Dogecoin
Ethereum
Litecoin
USD Coin
Contact us:
512.354.7000